1

5 Simple Statements About ABBV-744 clinical trial phase 1 results Explained

News Discuss 
In Phase A, participants will obtain distinctive doses and schedules of oral ABBV-744 tablet to discover safe dosing program. Extra members will be enrolled with the discovered monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be supplied as "add-on" therapy. In Segment C, participants https://rudye443sdn7.wssblogs.com/profile

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story